Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enanta Pharmaceuticals Inc (NASDAQ:ENTA)

37.96
Delayed Data
As of Aug 18
 -1.55 / -3.92%
Today’s Change
21.53
Today|||52-Week Range
41.20
+13.31%
Year-to-Date

Today’s Trading

Previous close39.51
Today’s open39.19
Day’s range37.92 - 39.45
Volume166,199
Average volume (3 months)186,438
Market cap$754.2M
Dividend yield--
Data as of 3:59pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)-72.37%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-45.13%
P/E ratioNM
Price/Sales5.80
Price/Book2.79

Competitors

 Today’s
change
Today’s
% change
AKAOAchaogen Inc+0.33+1.84%
INSMInsmed Inc+0.08+0.66%
TGTXTG Therapeutics Inc-0.15-1.36%
ACRSAclaris Therapeutics...-0.30-1.19%
Data as of 4:00pm ET, 08/18/2017

Financials

Next reporting dateNovember 20, 2017
EPS forecast (this quarter)$1.78
Annual revenue (last year)$88.3M
Annual profit (last year)$21.7M
Net profit margin24.55%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jay R. Luly
CFO, Principal Accounting Officer &
SVP-Finance
Paul J. Mellett
Corporate headquarters
Watertown, Massachusetts

Forecasts